Introduction Long-acting injectable antipsychotics (LAIA) have provided a significant improvement in the treatment of schizophrenia. Although there is already clinical experience with paliperidone palmitate, it important to evaluate response patients this new 6-monthly presentation, so descriptive studies based on real evidence can be very useful for purpose. Objectives The main objective study...
